z-logo
open-access-imgOpen Access
New Biochemical Pathway May Control Erection
Author(s) -
Thomas Mills
Publication year - 2001
Publication title -
the scientific world journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.453
H-Index - 93
eISSN - 2356-6140
pISSN - 1537-744X
DOI - 10.1100/tsw.2001.29
Subject(s) - erectile dysfunction , sildenafil , medicine , tadalafil , intensive care medicine , sexual intercourse , psychological therapy , surgery , psychiatry , population , anxiety , environmental health
Thirty million men in the U.S. suffer from erectile dysfunction (ED) defined by their inability to achieve or maintain a penile erection sufficient for intercourse. An unestimated number of women also suffer from sexual dysfunction resulting from many of the same causes that lead to ED in men. There are a variety of treatments available for ED including intracavernosal injection, transurethral therapy, surgery, vacuum therapy, and oral medication. Unfortunately, not all patients benefit from these currently available forms of therapy, and side effects are not uncommon. Sildenafil (Viagra) has been a highly successful drug for the treatment of ED but it does not work in all men . Some may experience a variety of side effects, and Viagra is contraindicated to some cardiac medications. These problems point to the need for new and different approaches to the treatment of sexual problems.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom